Back
Wednesday, 15 Nov, 2023
Duke-NUS clinician-scientists recognised in global rankings of highly cited scientists by Clarivate and Stanford University
Seven Duke-NUS clinician-scientists and researchers were named among Clarivate’s Highly Cited Researchers list for 2023, released on 15 November. In addition, more than 85 researchers from the School and the SingHealth Duke-NUS Academic Medical Centre (AMC) featured in Stanford University’s World’s Top 2% Scientists List, released in October 2023.
The high-impact nature of their translational research has earned many of them placings in previous editions of these rankings. Notably, Professors Antonio Bertoletti from the Emerging Infectious Diseases Programme and Derek Hausenloy from the Cardiovascular and Metabolic Disorders Programme have made the Clarivate list for a third consecutive time.
The Highly Cited Researchers list, curated by Clarivate annually, identifies individuals who have demonstrated significant and broad influence in their field or fields of research. Clarivate selects highly cited researchers from the world’s population of scientists through a complex evaluation and selection strategy. Besides citation activity, the number of shortlisted scientists is further refined through qualitative analysis and expert judgement.
This year, Clarivate issued a total of 7,125 highly cited researcher designations to 6,849 researchers from institutions in 67 countries and regions—3,793 in specific fields and 3,332 for cross-field impact.
Both Profs Bertoletti and Hausenloy were recognised for their cross-field impact. Also on the list are Senior Research Fellow Dr Anthony Tan as well as adjunct Senior Research Fellow Dr Chia Wan Ni and Professor Jenny Low from the Emerging Infectious Diseases Programme, both making their mark on the world stage for a second year.
Repeat accolades were also bestowed upon Professor Wang Linfa from the Emerging Infectious Diseases Programme and Professor Carolyn Lam from the SingHealth Duke-NUS Cardiovascular Sciences Academic Clinical Programme, who earned their spots in the fields of microbiology and clinical medicine, respectively.
Among the seven who made the Clarivate ranking, many also achieved a percentile rank of two per cent or above in the Stanford’s comprehensive ranking, a database comprising 100,000 of the most-cited scientists across 22 scientific fields. This ranking, compiled by Professor John Ioannidis and his team, is generated by comparing the composite indicator or c-score for researchers and considers six citation metrics in the analysis.
The Stanford ranking recognised more than 85 researchers from across the School’s Signature Research Programmes and the AMC, including Duke-NUS Dean Professor Thomas Coffman, Senior Vice-Dean for Research Professor Patrick Tan, Duke-NUS Health Services & Systems Research Programme Professor Tazeen H Jafar as well as Professor Lok Shee Mei from the Emerging Infectious Diseases Programme.
Extending his well wishes to the researchers, Prof Tan said: “My heartiest congratulations to our scientists, who have consistently demonstrated their commitment to advancing scientific knowledge and translating innovations from the bench to bedside to uplift the lives of people in our community and around the world. We take great pride in their remarkable accomplishments, which continue to transform medicine and improve lives.”
Cross-field
Jenny Low
Professor,
Emerging Infectious Diseases Programme
Chia Wan Ni
Adjunct Senior Research Fellow,
Emerging Infectious Diseases Programme
Anthony Tanoto Tan
Senior Research Fellow,
Emerging Infectious Diseases Programme
Microbiology
Wang Linfa
Professor,
Emerging Infectious Diseases Programme
Clinical Medicine
Carolyn Lam
Professor,
SingHealth Duke-NUS Cardiovascular Sciences Academic Clinical Programme